chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Demyelination of the spinal cord at T8-10 9/10 pain in left foot, left leg, mid scapula, thoracic, lumbar and right toes, weakness both legs, numbness left ribs to left leg  and foot Painful neuralgia left thigh, left ankle and left foot Resolved paralysis of left waist to left toes
Severe thrombocytopenia detected 1/12/10. Platelet 2,000. Diagnosis ITP.
Pt recvd an Engerix B series of 3 doses according to 0,1,6 months schedule. Serum Hepatitis BSAB test was Negative @ F/U. Repeat dosage of Engerix-B was planned @ month #9.
This spontaneous report as received from a physician refers to a patient of unknown age and gender. The patient's medical history and concurrent conditions were not reported. On an unknown date, the patient was vaccinated with M-M-R II, (route of administration: subcutaneous). On an unknown date (reported as an unspecified time after receiving M-M-R), the patient developed fever and rash. The outcome of the events fever and rash was unknown. The causality of the events was not reported. This is one of the two reports received from the same reporter. Additional information has been requested.
19JUL93 pt recvd vax & by 730PM 19JUL leg was red & hot to touch; 20JUL AM leg, above the knee, was one & one half its' nl size & deeper red color; 22JUL leg above knee was twice nl size & purple in color; pain; dx allergic reaction;
COVID-19; COVID-19; This is a spontaneous report received from a contactable reporter (Nurse).  A 52-year-old female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Depression" (ongoing); "Drug allergies: Penicillin" (unspecified if ongoing), notes: Drug allergies: Penicillin. Concomitant medication(s) included: SERTRALINE taken for depression (ongoing). The following information was reported: COVID-19 (medically significant), DRUG INEFFECTIVE (medically significant) all with onset Feb2023, outcome "unknown" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (Feb2023) Positive, notes: positive rapid test; (Feb2023) Negative, notes: negative rapid testing; (Feb2023) Positive, notes: positive for 7 more days. Therapeutic measures were taken as a result of covid-19, drug ineffective.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5, BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Considering a plausible drug-event temporal association, a reasonable possibility that the events drug ineffective and Covid-19 are related to BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5) cannot be excluded.  This case will be reassessed should additional information become available.
Fever 101.3; shaky; chills; muscle aches; slight headache; This is a spontaneous report from a contactable consumer (patient). A 36-year-old female patient received BNT162B2 (PFIZER- BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration, administered in left arm on 07Mar2021 at 15:00 (Batch/Lot Number: EN6955) (at the age of 36-years-old) as dose 1, single for COVID-19 immunisation. The patient's medical history was not reported. The patient was not pregnant at time of vaccination. The patient was not diagnosed with COVID-19 prior to vaccination and had not been tested for COVID-19 post vaccination. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to COVID-19 vaccine. The patient previously took amoxicillin and experienced drug allergies. The patient experienced fever 101.3, shaky, chills, muscle aches and slight headache on 07Mar2021 at 20:00. The patient received no treatment for the events. The outcome of events was recovered on an unspecified date in 2021.  No follow-up attempts are possible. No further information is expected.
Patient found unresponsive and transported to ED. Currently hospitalized and admitted with following issues: Present on Admission: ? Intraventricular hemorrhage (HCC) ? Bilateral thalamic hemorrhage ? Acute encephalopathy ? Abnormal eye movements ? Respiratory failure requiring intubation (HCC) ? Mucoid impaction of bronchi
Left finger has paronychia; This is a spontaneous report from a non-contactable consumer. A 35-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on an unknown date in Mar2021 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. Medical history of the patient was reported as none. Concomitant medications were not reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Apr2021, the patient's left finger had paronychia. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the adverse event which included treatment with cephalexin (MANUFACTURER UNKNOWN) prescription. The clinical outcome of the event left finger has paronychia was not recovered at the time of this report.   No follow-up attempts are possible. No further information is expected.
I had Adverse Reactions to both vaccines ( and i had Covid prior) . But the second one caused very intense SE, abnormal one being fainting spells. They lasted about 7 hours i would say, basically if i would stand for even 1 minute i would feel myself starting to faint (i fainted before and know exactly the feeling). If i lay down then the feeling would go away. But the weakness,lightheadedness, severe and i mean SEVERE body aches were present that whole day. Even my taste changed to bitter (just like when i had Covid).  I know most of the SE are considered normal, but the fainting spells are not.
Shot hurt right away, worse by the minute never got better seen DR on 11/02/11 (2 weeks later) was put on Mobic for the first 5 days was getting better then by the last 3 days was coming back. Pain in shoulder struggle getting dressed & brushing hair. Getting another visit to Dr this next week. Lucky I ask for in my left arm. Shot was given high is shoulder have never had pain immediately after like this and then did not go away. I now can not lift my arm over my head to get dressed without severe pain. The only relief was with the Mobic and that was only the first 5-7 days.
JANSSEN COVID 19 VACCINE  Fever, muscle pain and chills, it started at 3 AM
Client is a 16 year old male who came in for his Pfizer 2nd dose. Client received a Pfizer pediatric (5-11 year old) vaccine.  Client's parents contacted the next day. Parents denied the client having any adverse symptoms at this time.
Pt admitted to the hospital with worsening SOB with COVID + diagnosis. Patient on 2L O2 she was started on decadron 6mg for 10 days and continued with home symbicort, Spiriva, and albuterol. She was given Molnupiravir.
Vision loss; zoster-related injuries; Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. The patient's medical history, concurrent conditions and concomitant medication use were not provided. During 2017, the patient was vaccinated with zoster vaccine live (ZOSTAVAX), (dose, frequency, route of administration, anatomical location, lot number and expiration date were not reported) as long-term prevention of shingles and zoster-related conditions. Subsequently to the patient's vaccination, on an unknown date, the patient was treated in the emergency room for vision loss and other zoster-related injuries. As a result the patient the patient had and would continue to suffer injuries, including but not limited to: mental and physical pain and suffering; medical care for these injuries; significant medical and related expenses as result of these injuries, including but not limited to medical losses and costs include care for hospitalization,  physical care monitoring, treatment medications, and supplies; diminished capacity for enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and would continue to suffer such losses, and damages in the future. The outcome of the events vision loss and herpes zoster was not recovered. Both events were considered to be related to zoster vaccine live (ZOSTAVAX). Upon internal review, the patient's vision loss was considered to be medically significant.
This report is being submitted per request of the Dept. of Health to submit all patients who tested positive for COVID19 after receipt of the COVID19 vaccine. No other adverse events reported. The patient tested positive for COVID19 on 12/29/20.
Information has been received from a registered nurse referring to a patient of unknown age and gender. The patient's medical history, concurrent condition and concomitant therapy were not reported. On 10-AUG-2016, the patient received two doses of GARDASIL 9 injection, 0.5 ml/dose (lot# L026602, expired date and route unknown) (product use issue). No adverse effect was reported. Additional information has been requested.
First 24 hours post vaccine ran fever of 102 degrees.  2nd day post vaccination, arm swollen at site and continued to clavicle and distally to just above elbow, firm, warm, tender.  No axillary or neck region lymphoadenopathy.
Diarrhea- fluids and bland diet.  Tingling and numbness in Left hand.
broke out in shingles on opposite side; This is a spontaneous report from a contactable consumer (patient herself). A 78-year-old female patient received her first dose of bnt162b2 (BNT162B2 also reported as Pfizer Covid vaccine, lot EL9261), via an unspecified route of administration on 15Jan2021 11:00 at SINGLE DOSE for Covid-19 immunisation. Medical history included blood cholesterol increased and high blood pressure. She takes other stuff for cholesterol and high blood pressure. The patient experienced broke out in shingles on opposite side on 15Jan2021. She was treating it with a steroid shot and taking acyclovir, 5 a day for 7 days and also methyl prednisone and it is a packet and takes 6 a day. Her doctor also gave her a compound to rub on it. The outcome of event was not recovered.
Patient complained of burning throughout entire arm and shoulder area for 1-2 weeks after administration of SQ shingles vaccination.
Pfizer-BioNTech COVID-19 Vaccine EUA  Received Pfizer-BioNTech COVID-19 Vaccine EUA on April 26th in left shoulder.  Left shoulder hurt on April 27th - could use it but it hurt a lot to use. Also had a headache and diarrhea.  April 28th Left arm still hurt to use about the same as the 27th (didn't use it much).  April 29th  Left arm felt different than other arm hard to describe it didn't hurt to use it was just weaker than right arm but not too much weaker. Left leg started feeling tingly like ants were crawling up it.  April 30th same as the 29th left arm felt different than other arm hard to describe it didn't hurt to use it was just weaker than right arm but not too much weaker. Left leg still felt tingly.  May 1st Left arm felt weaker than before but I could still lift things with both arms without noticing a considerable difference. Left leg felt weird not tingly anymore just different than right leg kind of numb. Had a limp when walking slowly.  May 2nd felt like left arm and left leg were somewhat numb and weaker than right side. Also noticed I have to concentrate more to move my toes on the left.  May 3rd left arm and left leg felt worse left side of face felt kind of numb like when dentists give you Novocain my face felt numb like that ( no difference in my tongue) but I didn't notice anything physically different about it. Left eye achy a little and it got a little blurry  May 4th left arm and leg numb and weak, still hard to move my toes, and left side of face feels weird I guess numb is the best way to describe it. Left eye still blurry a little achy but not much.  Summary: Left arm hurt at injection site, then whole arm hurt, now it feels weak and numb. Left leg felt tingly now it feels weak and numb. Left side of face feels kind of numb, left eye is blurrier than normal (I wear glasses), and I have had an off and on headache spanning this whole time.
13NOV92 pt recvd vax & devel chest pains, tightness of chest, SOB, lt arm began to get hard, red & difficult to move; became weak, lethargic, tightness in joints, hands aching; became agitated; also rapid pulse & air hunger;
Symptoms: Headache, body aches, chills, vomiting (4x), fatigue, pain at injection site; Duration: 24 hours; Treatment: Tylenol
Undiluted vial of pediatric Pfizer COVID-19 vaccine given; therefore a larger than recommended dose administered.
hosp w/temp 100 throat burning, swollen, glands or lymph nodes rt side of neck, general malaise. Family moved. Not in state. Unsure whether they moved to. Last communication with family was that sonw as recovering. 12/00
Information has been received from a registered pharmacist concerning a patient who "6 days ago" on 19-MAY-2011 was vaccinated with a dose of ZOSTAVAX (Merck) (Lot number not reported). The registered pharmacist reported that six days after administration of ZOSTAVAX (Merck), the patient was diagnosed with poison ivy dermatitis. At the time of the report, the patient's outcome was unknown. It was reported that the patient sought medical attention but the method was unknown. Additional information has been requested.
Patient got positive results of COVID-19 on 08-06-2021; Patient got positive results of COVID-19 on 08-06-2021; OTCs for fever; This is a spontaneous report from a contactable consumer or other non hcp. A 27-year-old non-pregnant female patient received bnt162b2 (BNT162B2, Lot Number: EP6955) via an intramuscular route of administration, administered in arm left on 23Mar2021 at 13:00 (age at the time of vaccination 27-years-old) as DOSE 1, SINGLE and dose 2 (Lot Number: EP6955) via an intramuscular route of administration, administered in arm left on 12Apr2021 at 13:00 (Age at the time of vaccination: 27-years-old) as DOSE 2, SINGLE for covid-19 immunisation. The patient had no known allergies. The patient medical history not reported. There were no concomitant medications reported. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not received any other medications within 2 weeks of vaccination. On 03Aug2021 at 08:00 AM, The patient got positive results of covid-19 on 08-06-2021 and OTCs for fever. The patient underwent lab tests and procedures which included polymerase chain reaction was positive on 05Aug2021. Therapeutic measures were taken as a result of OTCs for fever. Event occurred in a country different from that of the reporter. This may be a duplicate if the reporter also submitted directly to his/her local agency. The event OTCs for fever outcome was not recovered.
Two days post vax, the pt experienced scapular pain, chest pain on left side when she takes a deep breath, sensation of discomfort in throat on left side and puffiness, also redness and warmth at injection site.
Become pain free from the arthritic pain after getting the Moderna Covid-19 vaccine; This spontaneous case was reported by a consumer and describes the occurrence of THERAPEUTIC RESPONSE UNEXPECTED (Become pain free from the arthritic pain after getting the Moderna Covid-19 vaccine) in a  patient of an unknown age and gender who received mRNA-1273 (Spikevax) for COVID-19 vaccination.     The patient's past medical history included Arthritic pains.    On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced THERAPEUTIC RESPONSE UNEXPECTED (Become pain free from the arthritic pain after getting the Moderna Covid-19 vaccine). At the time of the report, THERAPEUTIC RESPONSE UNEXPECTED (Become pain free from the arthritic pain after getting the Moderna Covid-19 vaccine) outcome was unknown.        The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown.       No concomitant information was reported. No treatment information was reported.  Patient stated that she had read an article which says that there are patients who become pain free from the arthritic pain after getting the Moderna Covid-19 vaccine.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. Concurrent conditions and medical history were not reported. The pharmacist reported that on 12-JUL-2015, the patient was vaccinated with one improperly stored dose of PNEUMOVAX23 (lot number, expiration date was not reported, dose and route were not reported). No adverse effects were reported. This is one of several reports from the same source. Additional information has been requested.
small wound / at the injection site; blister / at the injection site; formed a scab at at the injection site; This case was reported by a nurse via call center representative and described the occurrence of injection site injury in a 58-year-old female patient who received Herpes zoster (Shingrix) (batch number 24DP5, expiry date 8th April 2022) for prophylaxis.   Concurrent medical conditions included multiple sclerosis. Concomitant products included ocrelizumab (Ocrevus).   On 26th March 2020, the patient received the 1st dose of Shingrix (intramuscular). On an unknown date, less than 2 months after receiving Shingrix, the patient experienced injection site injury, injection site blisters and injection site scab. On an unknown date, the outcome of the injection site injury was recovered/resolved and the outcome of the injection site blisters and injection site scab were unknown.   It was unknown if the reporter considered the injection site injury, injection site blisters and injection site scab to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported. The patient received Shingrix vaccine via intramuscular route in the left deltoid.  On an unknown date after receiving the vaccine the patient developed a small wound that was blister like and formed a scab at at the injection site.  The event resolved on its own without treatment on an unknown date 2 months after receiving the Shingrix vaccine. The reporter consented to follow up.
High grade fever of 103.4 for 8 straight hours. Body aches, migraine, nausea, double vision, dehydration. Have developed an allergy to Sulfa, which I have never had an issue with in the past. Have skin discoloration on both arms and face now still to this day. Noticing significant hearing issues now. Always feel sick and lethargic since the vaccine. Bartholan gland cyst persistant for 6+ months requiring 2 trips to the ER and several doctors visits.
have a really bad red rash on my stomach. It seems to be getting worse. Now I see it on my; I have a really bad rash on my stomach. It seems to be getting worse. Now I see it on my arms.; I had a fever. I stayed in bed all day. I was very sick.; I had chills and body aches; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (I had chills and body aches), RASH (have a really bad red rash on my stomach. It seems to be getting worse. Now I see it on my), RASH (I have a really bad rash on my stomach. It seems to be getting worse. Now I see it on my arms.) and PYREXIA (I had a fever. I stayed in bed all day. I was very sick.) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 047A21A and 001A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 26-Mar-2021, the patient experienced PAIN (I had chills and body aches) and PYREXIA (I had a fever. I stayed in bed all day. I was very sick.). On 27-Mar-2021, the patient experienced RASH (have a really bad red rash on my stomach. It seems to be getting worse. Now I see it on my) and RASH (I have a really bad rash on my stomach. It seems to be getting worse. Now I see it on my arms.). The patient was treated with IBUPROFEN at an unspecified dose and frequency. On 27-Mar-2021, PAIN (I had chills and body aches) and PYREXIA (I had a fever. I stayed in bed all day. I was very sick.) had resolved. At the time of the report, RASH (have a really bad red rash on my stomach. It seems to be getting worse. Now I see it on my) and RASH (I have a really bad rash on my stomach. It seems to be getting worse. Now I see it on my arms.) outcome was unknown.            No relevant concomitant medications reported.  Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) in response to the event was not applicable
Rash under both arms, back, neck , groin and waste area.; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash under both arms, back, neck , groin and waste area.) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Feb-2021, the patient experienced RASH (Rash under both arms, back, neck , groin and waste area.). At the time of the report, RASH (Rash under both arms, back, neck , groin and waste area.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Pt had a syncopal/vasovagal reaction (fear of needles).  BP 135/79 (88), HR 61, RR 16 -- > 121/81 (90), 66, 16.  VSS, juice and crackers given.  Pt stable and released from the vaccination site.  Recommended that the pt lay down for 2nd dose.
Injection site redness right after administration along with feeling hot At first, redness was going away but became worse and went to urgent care who diagnosed cellulitis on 2/19/2021 and prescribed antibiotics. Patient took 1 day of antibiotics then Narrative:
Sore arm; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 17-Mar-2021 and was forwarded to Moderna on 17-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 024M70A and 031L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PAIN IN EXTREMITY (Sore arm). On 17-Mar-2021, PAIN IN EXTREMITY (Sore arm) had resolved. Not Provided          Patient reported concomitant medications included all kinds of medicines and were too many to say.  No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 06-May-2021: Follow up received on 06-MAY-2021 contains no new information.